Table 3.
HR (95% CI) | P | HR (95% CI) | P | |
---|---|---|---|---|
|
||||
Male | Female | |||
CYP1A1 I462V | ||||
AA | Ref | Ref | ||
AG | 1.65 (0.88 - 3.10) | 0.12 | 1.99 (1.12 - 3.53) | 0.019 |
AG+GG | 1.65 (0.88 - 3.10) | 1.61 (0.91 - 2.86) | 0.09 | |
CYP1A1 Msp1 | ||||
TT | Ref | Ref | ||
TC | 1.34 (0.75 - 2.4) | 0.33 | 1.58 (0.99 - 2.5) | 0.052 |
TC+CC | 1.34 (0.74 - 2.41) | 0.33 | 1.39 (0.87 – 2.24) | 0.17 |
| ||||
MLH1 | MSH2 | |||
CYP1A1 I462V | ||||
AA | Ref | Ref | ||
AG | 1.3 (0.82 - 2.03) | 0.24 | 2.24 (1.22 - 4.12) | 0.009 |
AG+GG | 1.15 ( 0.79 - 1.81) | 0.52 | 2.06 (1.14 - 3.72) | 0.017 |
CYP1A1 Msp1 | ||||
TT | Ref | Ref | ||
TC | 1.3 (0.82 - 2.07) | 0.27 | 1.74 (1.12 - 2.69) | 0.013 |
TC+CC | 1.19 (0.74 - 1.91) | 0.46 | 1.62 (1.04 - 2.54) | 0.034 |
| ||||
White | Other | |||
CYP1A1 I462V | ||||
AA | Ref | Ref | ||
AG | 1.73 (1.09 - 2.77) | 0.021 | 2.19 (0.82 - 5.88) | 0.12 |
AG+GG | 1.53 (0.97 - 2.43) | 0.066 | 2.11 (0.8 - 5.63) | 0.13 |
CYP1A1 Msp1 | ||||
TT | Ref | Ref | ||
TC | 1.5 (0.99 - 2.26) | 0.052 | 1.04 (0.52 - 2.08) | 0.91 |
TC+CC | 1.41 (0.93 - 2.12) | 0.1 | 0.93 (0.44 - 1.96) | 0.85 |